Latest News & Features
Americas
Healthcare advocate Médecins Sans Frontières has urged Indian Prime Minister Narendra Modi not to change IP laws which allow for the production of generic medicines. 30 September 2014
Americas
Research organisation Horizon Discovery Group has bought Sage Labs in a deal worth almost $50 million, a move that will strengthen its IP portfolio, the company has announced. 29 September 2014
Americas
A trade deal between the EU and Canada, due to be signed today if last-minute German concerns can be overcome, would have implications for pharmaceutical IP protection and could raise the cost of drugs in Canada, a report has claimed. 26 September 2014
Americas
A US court has ordered medical technology company Boston Scientific Corporation to pay $309 million to the family of the late physician Michel Mirowski in the latest chapter of their long running patent dispute. 26 September 2014
Asia
Law firm Miller, Canfield, Paddock & Stone has expanded its IP team in China with the appointment of life sciences specialist Kening Li. 24 September 2014
Americas
Generic drug maker Par Pharmaceutical Companies has settled a long running dispute with Salix Pharmaceuticals over its heartburn drug Zegerid (omeprazole/sodium bicarbonate). 23 September 2014
Biotechnology
UK-based cancer drug company Sareum has been granted a patent for an invention forming part of its treatment methods. 22 September 2014
Asia
Indian drug maker Cipla has signed a deal with Salix Pharmaceuticals allowing the US-based company exclusive rights relating to the Rifaximin Complexes patent family. 19 September 2014
Asia
US biotechnology company Gilead has agreed a licensing deal with seven Indian drug makers that will enable them to sell a generic version of a drug used to treat hepatitis C. 17 September 2014